journal
https://read.qxmd.com/read/38649788/t-cells-in-testicular-germ-cell-tumors-new-evidence-of-fundamental-contributions-by-rare-subsets
#1
JOURNAL ARTICLE
Rashidul Islam, Jannis Heyer, Miriam Figura, Xiaoyan Wang, Xichen Nie, Benedict Nathaniel, Sivanjah Indumathy, Katja Hartmann, Christiane Pleuger, Monika Fijak, Sabine Kliesch, Florian Dittmar, Adrian Pilatz, Florian Wagenlehner, Mark Hedger, Bruce Loveland, James H Hotaling, Jingtao Guo, Kate L Loveland, Hans-Christian Schuppe, Daniela Fietz
BACKGROUND: Immune cell infiltration is heterogeneous but common in testicular germ cell tumors (TGCT) and pre-invasive germ cell neoplasia in situ (GCNIS). Tumor-infiltrating T cells including regulatory T (Treg) and follicular helper T (Tfh) cells are found in other cancer entities, but their contributions to TGCT are unknown. METHODS: Human testis specimens from independent patient cohorts were analyzed using immunohistochemistry, flow cytometry and single-cell RNA sequencing (scRNA-seq) with special emphasis on delineating T cell subtypes...
April 22, 2024: British Journal of Cancer
https://read.qxmd.com/read/38649787/comment-on-neoadjuvant-chemotherapy-is-noninferior-to-chemoradiotherapy-for-early-onset-locally-advanced-rectal-cancer-in-the-fowarc-trial
#2
LETTER
Letian Qiao, Yuan Liu, Qiumin Yang
No abstract text is available yet for this article.
April 22, 2024: British Journal of Cancer
https://read.qxmd.com/read/38643339/tumour-associated-myeloid-cells-expressing-il-10r2-il-22r1-as-a-potential-biomarker-for-diagnosis-and-recurrence-of-pancreatic-ductal-adenocarcinoma
#3
JOURNAL ARTICLE
Hyung Keun Lee, So Young Kim, Soo-Hyun Chung, Bongkun Choi, Ji-Eun Kim, Dohee Yoon, Sung Ill Jang, Areum Yeo, Hyun Goo Kang, Jusung Lee, Yoon Ha Choi, Joon Seong Park, Yoolim Sung, Jong Kyoung Kim, Eun-Ju Chang, Dong Ki Lee
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor survival rate, largely due to the lack of early diagnosis. Although myeloid cells are crucial in the tumour microenvironment, whether their specific subset can be a biomarker of PDAC progression is unclear. METHODS: We analysed IL-22 receptor expression in PDAC and peripheral blood. Additionally, we analysed gene expression profiles of IL-10R2+ /IL-22R1+ myeloid cells and the presence of these cells using single-cell RNA sequencing and murine orthotropic PDAC models, respectively, followed by examining the immunosuppressive function of IL-10R2+ /IL-22R1+ myeloid cells...
April 20, 2024: British Journal of Cancer
https://read.qxmd.com/read/38643338/vaccination-and-screening-strategies-to-accelerate-cervical-cancer-elimination-in-norway-a-model-based-analysis
#4
JOURNAL ARTICLE
Allison Portnoy, Kine Pedersen, Jane J Kim, Emily A Burger
BACKGROUND: Experts have proposed an 'EVEN FASTER' concept targeting age-groups maintaining circulation of human papillomavirus (HPV). We explored effects of the vaccination component of these proposals compared with cervical cancer (CC) screening-based interventions on age-standardized incidence rate (ASR) and CC elimination (<4 cases/100,000) timing in Norway. METHODS: We used a model-based approach to evaluate HPV vaccination and CC screening scenarios compared with a status-quo scenario reflecting previous vaccination and screening...
April 20, 2024: British Journal of Cancer
https://read.qxmd.com/read/38643337/navigating-therapeutic-strategies-hpv-classification-in-head-and-neck-cancer
#5
REVIEW
Hossein Tabatabaeian, Yuchen Bai, Ruihong Huang, Akhilanand Chaurasia, Charbel Darido
The World Health Organisation recognised human papillomavirus (HPV) as the cause of multiple cancers, including head and neck cancers. HPV is a double-stranded DNA virus, and its viral gene expression can be controlled after infection by cellular and viral promoters. In cancer cells, the HPV genome is detected as either integrated into the host genome, episomal (extrachromosomal), or a mixture of integrated and episomal. Viral integration requires the breakage of both viral and host DNA, and the integration rate correlates with the level of DNA damage...
April 20, 2024: British Journal of Cancer
https://read.qxmd.com/read/38637603/association-between-trajectories-of-adherence-to-endocrine-therapy-and-risk-of-treated-breast-cancer-recurrence-among-us-nonmetastatic-breast-cancer-survivors
#6
JOURNAL ARTICLE
Ching-Yuan Chang, Bobby L Jones, Juan M Hincapie-Castillo, Haesuk Park, Coy D Heldermon, Vakaramoko Diaby, Debbie L Wilson, Wei-Hsuan Lo-Ciganic
BACKGROUND: Endocrine therapy is the mainstay treatment for breast cancer (BC) to reduce BC recurrence risk. During the first year of endocrine therapy use, nearly 30% of BC survivors are nonadherent, which may increase BC recurrence risk. This study is to examine the association between endocrine therapy adherence trajectories and BC recurrence risk in nonmetastatic BC survivors. METHODS: This retrospective cohort study included Medicare beneficiaries in the United States (US) with incident nonmetastatic BC followed by endocrine therapy initiation in 2010-2019 US Surveillance, Epidemiology, and End Results linked Medicare data...
April 18, 2024: British Journal of Cancer
https://read.qxmd.com/read/38627607/fgfr4-driven-plasticity-in-breast-cancer-progression-and-resistance-to-therapy
#7
REVIEW
Marcin Braun, Dominika Piasecka, Rafal Sadej, Hanna M Romanska
Breast cancer (BCa) is a complex and heterogeneous disease, with different intrinsic molecular subtypes that have distinct clinical outcomes and responses to therapy. Although intrinsic subtyping provides guidance for treatment decisions, it is now widely recognised that, in some cases, the switch of the BCa intrinsic subtype (which embodies cellular plasticity), may be responsible for therapy failure and disease progression. Aberrant FGFR4 signalling has been implicated in various cancers, including BCa, where it had been shown to be associated with aggressive subtypes, such as HER2-enriched BCa, and poor prognosis...
April 17, 2024: British Journal of Cancer
https://read.qxmd.com/read/38622286/blockade-of-tgf-%C3%AE-and-pd-l1-by-bintrafusp-alfa-promotes-survival-in-preclinical-ovarian-cancer-models-by-promoting-t-effector-and-nk-cell-responses
#8
JOURNAL ARTICLE
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W Craig
BACKGROUND: Failure of immunotherapy in high-grade serous ovarian cancer (HGSC) may be due to high levels of transforming growth factor-β (TGF-β) in ascites or tumour immune microenvironment (TIME). Here, we test whether coordinated blockade of TGF-β and PD-L1 with bintrafusp alfa (BA) can provoke anti-tumour immune responses in preclinical HGSC models. METHODS: BA is a first-in-class bifunctional inhibitor of TGF-β and PD-L1, and was tested for effects on overall survival and altered TIME in syngeneic HGSC models...
April 15, 2024: British Journal of Cancer
https://read.qxmd.com/read/38615108/predictable-changes-in-the-accuracy-of-human-papillomavirus-tests-after-vaccination-review-with-implications-for-performance-monitoring-in-cervical-screening
#9
REVIEW
Matejka Rebolj, Adam R Brentnall, Kate Cuschieri
Vaccination against human papillomavirus (HPV) is changing the performance of cytology as a cervical screening test, but its effect on HPV testing is unclear. We review the effect of HPV16/18 vaccination on the epidemiology and the detection of HPV infections and high-grade cervical lesions (CIN2+) to evaluate the likely direction of changes in HPV test accuracy. The reduction in HPV16/18 infections and cross-protection against certain non-16/18 high-risk genotypes, most notably 31, 33, and/or 45, will likely increase the test's specificity but decrease its positive predictive value (PPV) for CIN2+...
April 13, 2024: British Journal of Cancer
https://read.qxmd.com/read/38615107/radiation-reveal-moving-from-research-engagement-to-involvement
#10
REVIEW
Lisa Whittaker, Jamie A Dean, Catarina Veiga, Sophie Langdon, Rebecca Drake, Daniel Taylor, Myfanwy-Cerys Williams, Holly Masters, Alex Britton, Mia Cumbo, Nicole Burdis, Kate Mason, Gemma Fay, Emma Smith, Sam Benson, Alfie Halil, Sophie Lambert, Mark N Gaze, Jenny Gains, Bella Spencer, Alice Taylor-Gee, Samantha Y A Terry
Here, we report on the process of a highly impactful and successful creative, collaborative, and multi-partner public engagement project, Radiation Reveal. It brought together ten young adults aged 17-25-year-olds with experience of radiotherapy with researchers at Cancer Research UK RadNet City of London across three 2-hour online workshops. Our aims were to 1) initiate discussions between young adults and radiation researchers, and 2) identify what people wish they had known about radiotherapy before or during treatment...
April 13, 2024: British Journal of Cancer
https://read.qxmd.com/read/38605247/single-cell-sequencing-reveals-vegfr-as-a-potential-target-for-car-t-cell-therapy-in-chordoma
#11
JOURNAL ARTICLE
Huantong Wu, Xinqiang Li, Boyan Zhang, Penghao Liu, Maoyang Qi, Yueqi Du, Can Zhang, Wanru Duan, Zan Chen
BACKGROUND: Chordomas are rare osseous neoplasms with a dismal prognosis when they recur. Here we identified cell surface proteins that could potentially serve as novel immunotherapeutic targets in patients with chordoma. METHODS: Fourteen chordoma samples from patients attending Xuanwu Hospital Capital Medical University were subjected to single-cell RNA sequencing. Target molecules were identified on chordoma cells and cancer metastasis-related signalling pathways characterised...
April 11, 2024: British Journal of Cancer
https://read.qxmd.com/read/38600327/spp1-represents-a-therapeutic-target-that-promotes-the-progression-of-oesophageal-squamous-cell-carcinoma-by-driving-m2-macrophage-infiltration
#12
JOURNAL ARTICLE
Chen Wang, Yutong Li, Linhong Wang, Yu Han, Xiaohui Gao, Tiandong Li, Man Liu, Liping Dai, Renle Du
BACKGROUND: Tumour-associated macrophages (TAMs) are an important component of the tumour microenvironment (TME). However, the crosstalk between oesophageal squamous cell carcinoma (ESCC) cells and TAMs remains largely unexplored. METHODS: Clinical samples and the TCGA database were used to evaluate the relevance of SPP1 and TAM infiltration in ESCC. Mouse models were constructed to investigate the roles of macrophages educated by SPP1 in ESCC. Macrophage phenotypes were determined using qRT‒PCR and immunohistochemical staining...
April 10, 2024: British Journal of Cancer
https://read.qxmd.com/read/38600326/neratinib-could-be-effective-as-monotherapy-or-in-combination-with-trastuzumab-in-her2-low-breast-cancer-cells-and-organoid-models
#13
JOURNAL ARTICLE
Maryam Arshad, Abul Azad, Phoebe Yuen Ka Chan, Vasanthy Vigneswara, Katharina Feldinger, Siti Norasikin Mohd Nafi, Eloise Laporte-Maguire, Carmela De Santo, Jianmin Zuo, Abeer M Shaaban, Anthony Kong
BACKGROUND: Previous studies have suggested that patients with HER2-low breast cancers do not benefit from trastuzumab treatment although the reasons remain unclear. METHODS: We investigated the effect of trastuzumab monotherapy and its combination with different HER2 targeting treatments in a panel of breast cancer cell lines and patient-derived organoids (PDOs) using biochemical methods and cell viability assays. RESULTS: Compared to sensitive HER2 over-expressing (IHC3 + ) breast cancer cells, increasing doses of trastuzumab could not achieve IC50 in MDA-MB-361 (IHC 2 + FISH + ) and MDA-MB-453 (IHC 2 + FISH-) cells which showed an intermediate response to trastuzumab...
April 10, 2024: British Journal of Cancer
https://read.qxmd.com/read/38600325/pathway-based-signatures-predict-patient-outcome-chemotherapy-benefit-and-synthetic-lethal-dependencies-in-invasive-lobular-breast-cancer
#14
JOURNAL ARTICLE
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare Isacke, Rachael Natrajan, Elinor Sawyer, Christopher J Lord, Syed Haider
BACKGROUND: Invasive Lobular Carcinoma (ILC) is a morphologically distinct breast cancer subtype that represents up to 15% of all breast cancers. Compared to Invasive Breast Carcinoma of No Special Type (IBC-NST), ILCs exhibit poorer long-term outcome and a unique pattern of metastasis. Despite these differences, the systematic discovery of robust prognostic biomarkers and therapeutically actionable molecular pathways in ILC remains limited. METHODS: Pathway-centric multivariable models using statistical machine learning were developed and tested in seven retrospective clinico-genomic cohorts (n = 996)...
April 10, 2024: British Journal of Cancer
https://read.qxmd.com/read/38594371/trajectory-patterns-and-cumulative-burden-of-cea-during-follow-up-with-non-small-cell-lung-cancer-outcomes-a-retrospective-longitudinal-cohort-study
#15
JOURNAL ARTICLE
Chunxia Li, Lizhu Liu, Ruimin You, Yanli Li, Hongjiang Pu, Ming Lei, Bingbing Fan, Jiali Lv, Mengmei Liu, Guanghong Yan, Zhenhui Li, Dingyun You, Tao Zhang
BACKGROUND: Previous studies of non-small cell lung cancer (NSCLC) focused on CEA measured at a single time point, ignoring serial CEA measurements. METHODS: This retrospective cohort included 2959 patients underwent surgery for stage I-III NSCLC. CEA trajectory patterns and long-term cumulative CEA burden were evaluated using the latent class growth mixture model. RESULTS: Four CEA trajectory groups were identified, named as low-stable, decreasing, early-rising and later-rising...
April 9, 2024: British Journal of Cancer
https://read.qxmd.com/read/38594370/dynamic-genomic-changes-in-methotrexate-resistant-human-cancer-cell-lines-beyond-dhfr-amplification-suggest-potential-new-targets-for-preventing-drug-resistance
#16
JOURNAL ARTICLE
Xiang-Ning Meng, Jin-Fa Ma, Yang-He Liu, Si-Qing Li, Xu Wang, Jing Zhu, Meng-Di Cai, Hui-Shu Zhang, Tiantian Song, Shukai Xing, Li-Qing Hou, Huan Guo, Xiao-Bo Cui, Jiang Han, Peng Liu, Guo-Hua Ji, Wen-Jing Sun, Jing-Cui Yu, Song-Bin Fu
BACKGROUND: Although DHFR gene amplification has long been known as a major mechanism for methotrexate (MTX) resistance in cancer, the early changes and detailed development of the resistance are not yet fully understood. METHODS: We performed genomic, transcriptional and proteomic analyses of human colon cancer cells with sequentially increasing levels of MTX-resistance. RESULTS: The genomic amplification evolved in three phases (pre-amplification, homogenously staining region (HSR) and extrachromosomal DNA (ecDNA))...
April 9, 2024: British Journal of Cancer
https://read.qxmd.com/read/38582812/cancer-associated-fibroblasts-expressing-fibroblast-activation-protein-and-podoplanin-in-non-small-cell-lung-cancer-predict-poor-clinical-outcome
#17
JOURNAL ARTICLE
Layla Mathieson, Lilian Koppensteiner, David A Dorward, Richard A O'Connor, Ahsan R Akram
BACKGROUND: Cancer-associated fibroblasts (CAFs) are a dominant cell type in the stroma of non-small cell lung cancer (NSCLC). Fibroblast heterogeneity reflects subpopulations of CAFs, which can influence prognosis and treatment efficacy. We describe the subtypes of CAFs in NSCLC. METHODS: Primary human NSCLC resections were assessed by flow cytometry and multiplex immunofluorescence for markers of fibroblast activation which allowed identification of CAF subsets...
April 6, 2024: British Journal of Cancer
https://read.qxmd.com/read/38582811/the-prognostic-value-of-mek-pathway-associated-estrogen-receptor-signaling-activity-for-female-cancers
#18
JOURNAL ARTICLE
Chun Wai Ng, Yvonne T M Tsang, David M Gershenson, Kwong-Kwok Wong
BACKGROUND: Other than for breast cancer, endocrine therapy has not been highly effective for gynecologic cancers. Endocrine therapy resistance in estrogen receptor positive gynecologic cancers is still poorly understood. In this retrospective study, we examined the estrogen receptor (ER) signaling pathway activities of breast, ovarian, endometrial, and cervical cancers to identify those that may predict endocrine therapy responsiveness. METHODS: Clinical and genomic data of women with breast and gynecological cancers were downloaded from cBioPortal for Cancer Genomics...
April 6, 2024: British Journal of Cancer
https://read.qxmd.com/read/38582810/drp1-inhibition-mediated-mitochondrial-elongation-abolishes-cancer-stemness-enhances-glutaminolysis-and-drives-ferroptosis-in-oral-squamous-cell-carcinoma
#19
JOURNAL ARTICLE
Zhen Wang, Shouyi Tang, Luyao Cai, Qing Wang, Dan Pan, Yunmei Dong, Hao Zhou, Jing Li, Ning Ji, Xin Zeng, Yu Zhou, Ying-Qiang Shen, Qianming Chen
BACKGROUND: Mitochondrial dynamics play a fundamental role in determining stem cell fate. However, the underlying mechanisms of mitochondrial dynamics in the stemness acquisition of cancer cells are incompletely understood. METHODS: Metabolomic profiling of cells were analyzed by MS/MS. The genomic distribution of H3K27me3 was measured by CUT&Tag. Oral squamous cell carcinoma (OSCC) cells depended on glucose or glutamine fueling TCA cycle were monitored by 13C-isotope tracing...
April 6, 2024: British Journal of Cancer
https://read.qxmd.com/read/38575733/correction-inhibition-of-the-aurka-yap1-axis-is-a-promising-therapeutic-option-for-overcoming-cetuximab-resistance-in-colorectal-cancer-stem-cells
#20
Anxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer, Laura Del Puerto-Nevado, Oscar Aguilera, Laura García-García, Carlos Galeano, Irene de Miguel, Juana Serrano-López, Natalia Baños, María Jesús Fernández-Aceñero, Juan Carlos Lacal, Enzo Medico, Jesús García-Foncillas, Arancha Cebrián
No abstract text is available yet for this article.
April 4, 2024: British Journal of Cancer
journal
journal
23366
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.